Search Results 131-140 of 44835 for Two-phase

  1. Phase 2 Study To Evaluate The Oral Combination Of Ixazomib (MLN9708) With Cyclophosphamide And Dexamethasone In Patients With Newly Diagnosed Or Relapsed And/or Refractory Multiple Myeloma - Mayo Clinic

    This is a phase 2, multicenter, open-label study in patients with Newly Diagnosed Multiple Myeloma (NDMM) who have not received prior systemic treatment for ...

  2. An Open-label, Phase 2 Basket Study Of Neratinib In Patients With Solid Tumors With Somatic Activating HER Mutations - Mayo Clinic

    This is an open-label, non-randomized, multicenter, multinational, Phase 2 study exploring the effectiveness and safety of neratinib as monotherapy or in ...

  3. Clinical trials - Oncology (Medical)

    This phase III trial studies whether inotuzumab ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

  4. Clinical trials - Oncology (Medical)

    This phase III trial studies whether inotuzumab ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

  5. Phase II Trial Of Standard Chemotherapy +Various Proton Beam Therapy (PBT) Doses For Unresectable Stage 2/3 Non-Small Cell Lung Cancer - Mayo Clinic

    This study is being done to study which dose of proton beam therapy (PBT) for unresectable stage 2/3 Non-Small Cell Lung Cancer. Participation eligibility.

  6. Phase 2 Study Of Ruxolitinib Versus Anagrelide In Subjects With Essential Thrombocythemia Who Are Resistant To Or Intolerant Of Hydroxyurea (RESET-272) - Mayo Clinic

    Phase 2 Study Of Ruxolitinib Versus Anagrelide In Subjects With Essential Thrombocythemia Who Are Resistant To Or Intolerant Of Hydroxyurea (RESET-272).

  7. A Phase 2 Study Of PRM-151 In Subjects With Myelofibrosis - Mayo Clinic

    PRM-151 is an investigational drug that is being developed for possible use in the treatment of myelofibrosis (MF), a disease in which the bone marrow, which is ...

  8. A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults with Idiopathic Pulmonary Fibrosis - Mayo Clinic

    A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults with Idiopathic Pulmonary Fibrosis · Overview · Participation ...

  9. Surgery - Clinical trials - Mayo Clinic

    The purpose of this study is to investigate outcomes for all patients with upper or lower extremity lymphedema with lymph node transfer in a two stage ...

  10. Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma - Mayo Clinic

    Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant ...